Pfizer has said that its antiviral pills to address COVID-19 edit the risk of hospitalization insurance or death in vulnerable grownup by almost 90 pct , replicating outcome froman interim analysisannounced last month . Data also suggest that the pill stands a good opportunity against the highly mutatedOmicron variant , which is currently spreading like wildfire in many share of the humans .
Inan announcementon Tuesday , December 14 , Pfizer revealed the full issue of its 2,246 - someone study investigating their anti - COVID treatment PAXLOVID .
They close that the pill reduce the risk of hospitalization and death in high - risk adults by 89 percent if given within three days of the onset of symptoms . It also reduced the risk of hospitalization or death for any cause by 88 percent compare to placebo in high - peril patients regale within five days of symptom onset . Importantly , the treatment produced very few adverse effects , most of which were relatively mild .
PAXLOVID is an oral pill that work by blocking the bodily process of an enzyme that SARS - CoV-2 , the computer virus that have COVID-19 , want to replicate . The latest results clear play up this effect , showing that the pill discussion results in an “ approximate 10 - fold decrease in viral load at day five , comparative to placebo . ” The idea is to give the drug to high - risk patient infect with COVID-19 as an oral antiviral therapy to reduce the risk of them requiring hospital care or death .
“ This news provide further corroboration that our oral antiviral candidate , if empower or approved , could have a meaningful impact on the lives of many , as the datum further digest the efficacy of PAXLOVID in repress hospitalization and dying and show a material lessening in viral load . This underscores the treatment candidate ’s electric potential to save the life of patients around the domain , ” Albert Bourla , Chairman and Chief Executive Officer of Pfizer , said in astatement .
“ Emerging variant of concern , like Omicron , have exacerbated the pauperization for approachable treatment options for those who contract the computer virus , and we are confident that , if authorized or approved , this potential treatment could be a vital peter to assist quench the pandemic . ”
